Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Closed Date5/2013

General Information

Offices

Fremont, USA
6300 Dumbarton Circle
Fremont, CA, 94555
USA

Funding

TOTAL $22M
FUNDING TOTAL $22M
Venture Round, 11/2008
New Enterprise Associates
MPM Capital
OrbiMed Advisors
$21.6M
Partial Close, 11/2009
$357k
DEBT TOTAL $6.3M
Debt, 8/2010
Lighthouse Capital Partners
$6.3M

Tags

ARYx Therapeutics Closed down May, 2013

ARYx Therapeutics

ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. They are focused on improving the safety of oral therapies for chronic disease.

Recent Milestones

Videos

Screenshots

ARYx Therapeutics screenshot
Above: ARYx Therapeutics
Uploaded: 7/15/09

Sources

  1. ARYx Therapeutics Inc. Announces $21.6 Million Private Placement (investors.aryx.com) [edit]
  2. SEC (sec.gov) [edit]
  3. ARYx stays afloat with $6.3M bridge loan (fiercebiotech.com) [edit]
Edit This Page
Last Edited 3/19/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy